The Potential Antidepressant Action of Duloxetine Co-Administered with the TAAR1 Receptor Agonist SEP-363856 in Mice
Here, we explored the possible interaction between duloxetine and SEP-363856 (SEP-856) in depression-related reactions. The results showed that oral administration of duloxetine showed powerful antidepressant-like effects in both the forced swimming test (FST) and the suspension tail test (TST). SEP...
Main Authors: | Xia Ren, Jiaying Xiong, Lingzhi Liang, Yin Chen, Guisen Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/9/2755 |
Similar Items
-
Effect of Co-Treatment of Olanzapine with SEP-363856 in Mice Models of Schizophrenia
by: Lingzhi Liang, et al.
Published: (2022-04-01) -
Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders
by: Savelii R. Kuvarzin, et al.
Published: (2023-07-01) -
Suspected duloxetine-induced restless legs syndrome phenotypic variant: a case report
by: Yan Shao, et al.
Published: (2024-05-01) -
Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia – a randomized clinical trial
by: Seyed Shahab Banihashem, et al.
Published: (2024-01-01) -
Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis
by: Filippo Migliorini, et al.
Published: (2023-07-01)